Omid Motabar is a Neurology physician affiliated with National Institutes of Health. OpenAlex indexes 101 publications with 714 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7315 Wisconsin Ave
Bethesda, MD 208143202
Telephone
240-837-9140Provider last certified this registry record 27 Jan 2023.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
82.9%Gabapentinoids13.7%Gabapentin68%Pregabalin32%Part D<11 patientsCholinesterase Inhibitor13%Donepezil Hcl100%Part D≥15 patients+ 8 more classes in this area
Cardiovascular
9.4%Statin6%Atorvastatin Calcium100%Part D<11 patientsBeta blocker3.4%Propranolol Hcl Er100%Part D<11 patientsBlood & clotting
3.9%Factor Xa inhibitor3.9%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Neural stem cells for disease modeling and evaluation of therapeutics for Tay-Sachs disease
Orphanet Journal of Rare Diseases
2018 - Disease models for the development of therapies for lysosomal storage diseases
Annals of the New York Academy of Sciences
2016 - Discovery, SAR, and Biological Evaluation of Non-inhibitory Chaperones of Glucocerebrosidase
Europe PMC (PubMed Central)
2013 - Discovery, SAR, and Biological Evaluation of a Non-Inhibitory Chaperone for Acid Alpha Glucosidase2013
Similar KOLs
Other experts from the same institution or the same specialty.
Edward Lakatta, MD
National Institutes of Health
Douglas Lowy, MD
National Institutes of Health
Jerome Fleg, MD
National Institutes of Health
Robert Star, MD
National Institutes of Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”